vs

Side-by-side financial comparison of Carter Bankshares, Inc. (CARE) and Meridian Corp (MRBK). Click either name above to swap in a different company.

Carter Bankshares, Inc. is the larger business by last-quarter revenue ($39.8M vs $34.2M, roughly 1.2× Meridian Corp). On growth, Carter Bankshares, Inc. posted the faster year-over-year revenue change (15.4% vs 5.1%). Carter Bankshares, Inc. produced more free cash flow last quarter ($31.8M vs $22.6M). Over the past eight quarters, Meridian Corp's revenue compounded faster (18.0% CAGR vs 9.1%).

Carter Bankshares, Inc. is a U.S. regional bank holding company operating Carter Bank & Trust, a community-focused financial institution. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, and wealth management services, primarily serving consumers and small business clients across Virginia and North Carolina.

Meridian Audio is a consumer audio and home theatre equipment manufacturer based in the United Kingdom. Bob Stuart and Allen Boothroyd founded the company in 1977 under the name Boothroyd-Stuart. In 1985 the company released a CD player under the brand name, Meridian. The company also created the lossless compression format Meridian Lossless Packing in 1998 and the lossy Master Quality Authenticated (MQA) format in 2014.

CARE vs MRBK — Head-to-Head

Bigger by revenue
CARE
CARE
1.2× larger
CARE
$39.8M
$34.2M
MRBK
Growing faster (revenue YoY)
CARE
CARE
+10.3% gap
CARE
15.4%
5.1%
MRBK
More free cash flow
CARE
CARE
$9.2M more FCF
CARE
$31.8M
$22.6M
MRBK
Faster 2-yr revenue CAGR
MRBK
MRBK
Annualised
MRBK
18.0%
9.1%
CARE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CARE
CARE
MRBK
MRBK
Revenue
$39.8M
$34.2M
Net Profit
$7.2M
Gross Margin
Operating Margin
27.8%
27.2%
Net Margin
428.0%
Revenue YoY
15.4%
5.1%
Net Profit YoY
28.3%
EPS (diluted)
$0.38
$0.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CARE
CARE
MRBK
MRBK
Q4 25
$39.8M
$34.2M
Q3 25
$39.1M
$33.1M
Q2 25
$37.3M
$32.4M
Q1 25
$37.0M
$27.1M
Q4 24
$34.5M
$32.6M
Q3 24
$34.2M
$29.1M
Q2 24
$33.6M
$26.1M
Q1 24
$33.5M
$24.6M
Net Profit
CARE
CARE
MRBK
MRBK
Q4 25
$7.2M
Q3 25
$5.4M
$6.7M
Q2 25
$8.5M
$5.6M
Q1 25
$9.0M
$2.4M
Q4 24
$5.6M
Q3 24
$5.6M
$4.7M
Q2 24
$4.8M
$3.3M
Q1 24
$5.8M
$2.7M
Operating Margin
CARE
CARE
MRBK
MRBK
Q4 25
27.8%
27.2%
Q3 25
18.3%
26.2%
Q2 25
28.5%
22.5%
Q1 25
30.1%
11.6%
Q4 24
31.0%
23.3%
Q3 24
20.5%
21.5%
Q2 24
17.6%
16.8%
Q1 24
21.6%
14.4%
Net Margin
CARE
CARE
MRBK
MRBK
Q4 25
428.0%
Q3 25
13.9%
20.1%
Q2 25
22.8%
17.2%
Q1 25
24.2%
8.9%
Q4 24
366.8%
Q3 24
16.4%
16.3%
Q2 24
14.3%
12.7%
Q1 24
17.4%
10.9%
EPS (diluted)
CARE
CARE
MRBK
MRBK
Q4 25
$0.38
$0.61
Q3 25
$0.24
$0.58
Q2 25
$0.37
$0.49
Q1 25
$0.39
$0.21
Q4 24
$0.36
$0.49
Q3 24
$0.24
$0.42
Q2 24
$0.21
$0.30
Q1 24
$0.25
$0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CARE
CARE
MRBK
MRBK
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
Stockholders' EquityBook value
$419.7M
$199.7M
Total Assets
$4.9B
$2.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Stockholders' Equity
CARE
CARE
MRBK
MRBK
Q4 25
$419.7M
$199.7M
Q3 25
$412.8M
$188.0M
Q2 25
$405.6M
$178.0M
Q1 25
$401.8M
$173.6M
Q4 24
$384.3M
$171.5M
Q3 24
$386.8M
$167.4M
Q2 24
$364.4M
$162.4M
Q1 24
$359.1M
$159.9M
Total Assets
CARE
CARE
MRBK
MRBK
Q4 25
$4.9B
$2.6B
Q3 25
$4.8B
$2.5B
Q2 25
$4.8B
$2.5B
Q1 25
$4.7B
$2.5B
Q4 24
$4.7B
$2.4B
Q3 24
$4.6B
$2.4B
Q2 24
$4.5B
$2.4B
Q1 24
$4.6B
$2.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CARE
CARE
MRBK
MRBK
Operating Cash FlowLast quarter
$39.9M
$24.3M
Free Cash FlowOCF − Capex
$31.8M
$22.6M
FCF MarginFCF / Revenue
79.9%
65.9%
Capex IntensityCapex / Revenue
20.2%
5.1%
Cash ConversionOCF / Net Profit
3.38×
TTM Free Cash FlowTrailing 4 quarters
$54.6M
$51.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CARE
CARE
MRBK
MRBK
Q4 25
$39.9M
$24.3M
Q3 25
$11.8M
$24.4M
Q2 25
$9.6M
$-12.0M
Q1 25
$6.4M
$18.1M
Q4 24
$36.9M
$9.6M
Q3 24
$10.3M
$31.2M
Q2 24
$-2.5M
$-19.2M
Q1 24
$17.6M
$-1.7M
Free Cash Flow
CARE
CARE
MRBK
MRBK
Q4 25
$31.8M
$22.6M
Q3 25
$10.3M
$24.0M
Q2 25
$7.7M
$-12.7M
Q1 25
$4.9M
$17.9M
Q4 24
$28.8M
$9.0M
Q3 24
$8.4M
$29.5M
Q2 24
$-4.3M
$-19.3M
Q1 24
$16.3M
$-3.6M
FCF Margin
CARE
CARE
MRBK
MRBK
Q4 25
79.9%
65.9%
Q3 25
26.3%
72.4%
Q2 25
20.6%
-39.1%
Q1 25
13.1%
65.9%
Q4 24
83.5%
27.7%
Q3 24
24.6%
101.4%
Q2 24
-12.7%
-73.8%
Q1 24
48.8%
-14.7%
Capex Intensity
CARE
CARE
MRBK
MRBK
Q4 25
20.2%
5.1%
Q3 25
3.9%
1.4%
Q2 25
5.1%
1.9%
Q1 25
4.1%
1.0%
Q4 24
23.6%
1.7%
Q3 24
5.5%
6.0%
Q2 24
5.4%
0.2%
Q1 24
3.9%
7.8%
Cash Conversion
CARE
CARE
MRBK
MRBK
Q4 25
3.38×
Q3 25
2.18×
3.66×
Q2 25
1.13×
-2.15×
Q1 25
0.71×
7.55×
Q4 24
1.71×
Q3 24
1.83×
6.58×
Q2 24
-0.51×
-5.78×
Q1 24
3.03×
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons